Evaluating the Feasibility of AI-Predicted mpMRI Image Features for Predicting Prostate Cancer Aggressiveness: a Multicenter Study

Author:

Wang Kexin1,Luo Ning2,Sun Zhaonan3,Zhao Xiangpeng2,She Lilan4,Xing Zhangli4,Chen Yuntian5,He Chunlei5,Wu Pengsheng6,Wang Xiangpeng6,Kong ZiXuan2

Affiliation:

1. Capital Medical University

2. the Second Affiliated Hospital of Dalian Medical University

3. Peking University First Hospital

4. Fujian Medical University Union Hospital

5. Sichuan University

6. Beijing Smart Tree Medical Technology Co. Ltd

Abstract

Abstract

Objective To evaluate the feasibility of utilizing artificial intelligence (AI)-predicted multiparametric MRI (mpMRI) image features for predicting the aggressiveness of prostate cancer (PCa). Materials and methods A total of 878 PCa patients from 4 hospitals were retrospectively collected, all of whom had pathological results after radical prostatectomy(RP).A pre-trained AI algorithm was used to select suspected PCa lesions and extract lesion features for model development. The study evaluated five prediction methods, including 1) A clinical model of clinical features and image features of suspected PCa lesions selected by AI algorithm, 2)the PIRADS category, 3)a conventional radiomics model, 4) a radiomics model based on deep learning, 5)biopsy pathology. Results In the externally validated dataset, the deep learn-based radiomics model showed the highest area under the curve (AUC 0.700 to 0.791).It exceeded clinical model (AUC 0.597 to 0.718), traditional radiomic model (AUC 0.566 to 0.632), PIRADS score (AUC 0.554 to 0.613) and biopsy pathology (AUC 0.537 to 0.578). And the AUC predicted by the model did not show statistically significant difference among the three externally verified hospitals (P > 0.05). Conclusion Deep-radiomics models utilizing AI-extracted image features from mpMRI images can potentially be used to predict PCa aggressiveness, demonstrating a generalized ability for external validation.

Publisher

Research Square Platform LLC

Reference40 articles.

1. WHO. Cancer. 2018. Accessed on October 26, 2020. Available from: https://www.who.int/health-topics/cancer#tab=tab_1

2. Mottet N BJ, Briers E, Bolla M, Cornford P, De Santis M. European Association of Urology Prostate Cancer Guidelines. 2020. https://uroweb.org/wp-content/uploads/EAU-Guidelines-Prostate-Cancer-2015-v2

3. Defining clinically significant prostate cancer on;Matoso A;the basis of pathological findings.Histopathology,2019

4. Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA et al (2016) The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma:Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol 40(2):244–252.

5. Radiologist-like artificial intelligence for grade group prediction of radical prostatectomy for reducing upgrading and downgrading from biopsy;Lizhi Shao Ye;Theranostics,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3